Emergent BioSolutions
EBS
#7677
Rank
ยฃ0.30 B
Marketcap
ยฃ6.01
Share price
-2.29%
Change (1 day)
29.58%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): ยฃ0.12 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are ยฃ0.75 Billion. In 2024 the company made an earning of -ยฃ54.31 Million, an increase over its 2023 earnings that were of -ยฃ0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.12 B-331.18%
2024 -ยฃ54.31 Million-88.82%
2023 -ยฃ0.49 Billion242.73%
2022 -ยฃ0.15 Billion-153.8%
2021 ยฃ0.26 B-20.43%
2020 ยฃ0.33 B278.02%
2019 ยฃ87.61 M27.11%
2018 ยฃ68.92 M-27.12%
2017 ยฃ94.58 M17.21%
2016 ยฃ80.69 M0.45%
2015 ยฃ80.33 M73.51%
2014 ยฃ46.3 M41.36%
2013 ยฃ32.75 M35.2%
2012 ยฃ24.22 M0.4%
2011 ยฃ24.13 M-56.46%
2010 ยฃ55.41 M76.73%
2009 ยฃ31.35 M32.94%
2008 ยฃ23.58 M-5.62%
2007 ยฃ24.99 M
2005 ยฃ36.18 M269.89%
2004 ยฃ9.78 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.99 B 6,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.93 B 7,856.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ7.56 B 5,956.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-ยฃ9.35 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
ยฃ68.19 M-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.71 B 1,273.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel